ArticlePloS one2025
Perceptions and practices of community pharmacists towards the use of short-acting beta-2 agonists inhalers in Malaysia: A cross-sectional survey.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Exploring patients' perspectives and experiences of asthma self-management: A qualitative study.Exploratory research in clinical and social pharmacy · 2026Article
- Article
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere has been a relative lack of exploration into the perceptions and practices regarding the use of SABA inhalers among healthcare professionals in Malaysia. The study aimed to determine community pharmacists' perceptions and practices towards using SABA inhalers at community pharmacies in Malaysia.
methodsIt was a cross-sectional study conducted using a self-administered, web-based survey (Google Form) among community pharmacists in Malaysia between 26th December 2022 and 25th May 2023. Descriptive statistics were used to summarize the participants' socio-demographic characteristics, and the Kruskal-Wallis and Mann-Whitney U tests were applied to continuous data and p < 0.05 was considered significant. Regression analysis was carried out to identify associated predictors of socio-demographic characteristics of the participants regarding perception of asthma control and management.
resultsA total of 312 community pharmacists completed the survey. Most of the participants were females (64.1%, n = 200), aged between 29 and 38 years (51.0%, n = 159). The majority of community pharmacists agreed that achieving good asthma control led to minimal asthma symptoms (n = 263, 84.3%) and fewer requirements for medical interventions (n = 204, 65.4%). Additionally, most participants were engaged in educating their patients about the correct techniques for using asthma inhalers (93.6%, n = 292) and provided sufficient information about the safe use of SABA inhalers (79.5%, n = 248). The most frequently perceived facilitator (n = 235, 75.4%) was providing additional follow-up sessions, and the primary perceived barrier (n = 232, 74.4%) was the lack of patients' awareness of the provided asthma care services.
conclusionCommunity pharmacists acknowledged that good asthma control was associated with minimal medical assistance and symptoms. However, some concerns were expressed over asthma patients' purchase of non-prescription SABA inhalers. The participants perceived some barriers, such as lack of patient awareness regarding the asthma care services availability that might hinder the safe use of SABA inhalers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.